An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP)

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

August 31, 2015

Conditions
Immune Thrombocytopenia
Interventions
DRUG

Dexamethasone

Dexamethasone was given at a dose of 40 mg,daily for 4 consecutive days

DRUG

Dexamethasone

Dexamethasone was given at a dose of 20 mg,daily for 4 consecutive days

Trial Locations (1)

250012

Qilu Hospital, Shandong University, Jinan

All Listed Sponsors
collaborator

Chinese Academy of Medical Sciences

OTHER

collaborator

Shandong Provincial Hospital

OTHER_GOV

collaborator

The First Affiliated Hospital of Dalian Medical University

OTHER

collaborator

Peking Union Medical College Hospital

OTHER

collaborator

Shandong University of Traditional Chinese Medicine

OTHER

collaborator

Anhui Provincial Hospital

OTHER_GOV

collaborator

Second Hospital of Shanxi Medical University

OTHER

lead

Shandong University

OTHER

NCT02153060 - An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP) | Biotech Hunter | Biotech Hunter